Suzanne Roghieh Saffie-Siebert
Director Ejecutivo en SiSaf Ltd. .
Cargos activos de Suzanne Roghieh Saffie-Siebert
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SiSaf Ltd.
SiSaf Ltd. BiotechnologyHealth Technology SiSaf Ltd. engages in the design and formulation of drugs for topical delivery systems. Its proprietary technology represents a highly effective, non-irritant carrier for cosmetic and medical products, where improved skin penetration, targeting, and controlled release are required. The firm uses nanosilicon as a carrier for active compounds allowing them to penetrate deep beneath the skin's epidermal barrier for controlled release. It operates through its offices located in Belfast and San Jose. The company was founded by Suzanne Roghieh Saffie-Siebert and Timothy John Brundle in 2006 and is headquartered in Belfast, the United Kingdom. | Director Ejecutivo | 23/09/2011 | - |
Fundador | 23/09/2011 | - |
Historial de carrera de Suzanne Roghieh Saffie-Siebert
Antiguos cargos conocidos de Suzanne Roghieh Saffie-Siebert.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Dompé SpA
Dompé SpA Pharmaceuticals: MajorHealth Technology Dompé SpA provides services of updating and scientific assistance to doctors. It offers information on therapeutic areas including physiatrics, cystic fibrosis, geriatrics, infectious diseases, internal, sleep and sports medicine, odontology, orthopedics and traumatology, otorhinolaryngology, pediatrics, pneumology, and emergency and drugs. The company was founded by Sergio Dompé in 1993 and is headquartered in L'Aquila, Italy. | Corporate Officer/Principal | - | - |
Autism Biotech Ltd.
Autism Biotech Ltd. BiotechnologyHealth Technology Autism Biotech Ltd. researches and develops biotechnology. The company was founded by Suzanne Roghieh Saffie-Siebert in 2012 and is headquartered in Queens Island, the United Kingdom. | Director Ejecutivo | 01/01/2012 | - |
Fundador | 01/01/2012 | - | |
pSiMedica Ltd.
pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Director Técnico/Científico/I+D | - | - |
Formación de Suzanne Roghieh Saffie-Siebert.
University of London | Doctorate Degree |
Estadísticas
Internacional
Reino Unido | 5 |
Italia | 2 |
Operativa
Chief Executive Officer | 2 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
pSiMedica Ltd.
pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Commercial Services |
Dompé SpA
Dompé SpA Pharmaceuticals: MajorHealth Technology Dompé SpA provides services of updating and scientific assistance to doctors. It offers information on therapeutic areas including physiatrics, cystic fibrosis, geriatrics, infectious diseases, internal, sleep and sports medicine, odontology, orthopedics and traumatology, otorhinolaryngology, pediatrics, pneumology, and emergency and drugs. The company was founded by Sergio Dompé in 1993 and is headquartered in L'Aquila, Italy. | Health Technology |
SiSaf Ltd.
SiSaf Ltd. BiotechnologyHealth Technology SiSaf Ltd. engages in the design and formulation of drugs for topical delivery systems. Its proprietary technology represents a highly effective, non-irritant carrier for cosmetic and medical products, where improved skin penetration, targeting, and controlled release are required. The firm uses nanosilicon as a carrier for active compounds allowing them to penetrate deep beneath the skin's epidermal barrier for controlled release. It operates through its offices located in Belfast and San Jose. The company was founded by Suzanne Roghieh Saffie-Siebert and Timothy John Brundle in 2006 and is headquartered in Belfast, the United Kingdom. | Health Technology |
Autism Biotech Ltd.
Autism Biotech Ltd. BiotechnologyHealth Technology Autism Biotech Ltd. researches and develops biotechnology. The company was founded by Suzanne Roghieh Saffie-Siebert in 2012 and is headquartered in Queens Island, the United Kingdom. | Health Technology |